GSK and PFV Rolls Out Kontra Diarrhea Campaign

The preventable and treatable disease is still the second leading cause of death in
children under the age of five.

My mother was so sick and confined at the Hospital in ICU. I'm taking care of her and I don't want to leave her in that kind of situation! But my husband called me saying that our baby was also sick! My baby was vomiting and having a diarrhea at the same time. He has no appetite to eat food or even drink his milk. He might get dehydrated and I really need to go home to breastfeed him!

When I got home, I breastfeed him immediately, check his temperature and observed him, until we decided to go at the Emergency. I've decided to go at the Hospital where my mom was also confined, so I can check her also.

At the hospital, they took blood test and urine test and I still continued breastfeeding him. The good thing was I already had him vaccinated with rota virus hence we only stayed at the ER just for a few hours. They only put him on iv to replenish and hydrate him.

The point is, children may still have diarrhea but with rota virus vaccine, hospitalization or period of sickness will be shorter.

Despite advances in modern medicine, children under the age of five are still susceptible to diarrhea—a disease that has been identified as the second leading cause of death in children worldwide, next to pneumonia. The World Health Organization (WHO) reported that diarrhea kills about half a million children aged under five each year. In the Philippines, it is also one of the
leading causes of death among children, translating to 14 Filipino children dying of
the disease every day before they reach the age of 5.

Rotavirus is the number one cause of severe, dehydrating diarrhea. This virus is
highly contagious and can spread via fecal- oral route. It is readily transmitted from
contaminated surfaces, such as when infants and young children frequently put
their hands and toys into their mouths. The virus has also sent millions of infants
and young children to hospitals and clinics.

Studies have shown that a child who has experienced severe, dehydrating diarrhea
may suffer from its long-term effects such as loss of IQ by up to 10 points, fitness
impairment, decreased school performance including delayed school age.
It is a universal disease that our children can acquire, rich or poor.

To combat the threat of diarrhea, GSK, one of the world’s science- led healthcare
companies, in partnership with the Philippine Foundation for Vaccination (PFV), officially launched the “Game On: Kontra Diarrhea” campaign on October 10. The campaign aims to emphasize the gravity of the disease and a holistic approach to its prevention, which includes breastfeeding, improvement of hygiene and clean water supply, handwashing, and vaccination.

“We want to inform and empower mothers all over the Philippines to give their
children a better chance to a brighter future. Rotavirus diarrhea can seriously
impact on a child’s growth and development. A holistic approach—breastfeeding, access to clean water and sanitation, handwashing, and vaccination—has been considered to give Filipino infants and young children a chance against this life-threatening disease,” said Dr. Lulu Bravo, Executive Director of the PFV.

"Helping protect our Filipino children from vaccine - preventable diseases such as diarrhea has always been a continuing commitment and advocacy of the PFV," shared Dr. Bravo.

Vaccinating a child against Rotavirus has been considered generally safe and effective based on data from countries who have implemented national rotavirus vaccination programs. In line with the WHO recommendation, there are more than 80 countries that have implemented this measure such as Philippines, Thailand, United States, and the United Kingdom. Hospitalization rates and diarrheal deaths in these countries, have declined.

"Diarrhea has been a long-standing health issue around the world and in the Philippines. The time is now for us act on it by increasing awareness amongst the public on the serious consequences of diarrhea among children," said Sriram Jambunathan, General Manager of GSK Philippines.

"We will continue to help raise awareness on childhood diarrhea in some of the communities in the provinces with the highest diarrhea cases. All of us - industry, doctors, policymakers, and the civil society - - need to work together to help ensure that our children remain healthy and protected from diarrhea," urged Jambunathan.

This year, GSK commemorates its 50th year in the Philippines and commits to continue helping Filipinos do more, feel better, live longer.

The Game On: Kontra Diarrhea Caravan will be in Agusan on October 17, Iloilo on October 23, Manila on October 25 and finally in Dagupan on November 5.

To know more about the childhood diarrhea and how to prevent it, consult your doctor or community health worker.

Executives Profiles:

SRIRAM JAMBUNATHAN

General Manager, GSK Philippines

PROFESSIONAL EXPERIENCE

• GSK Philippines - General Manager, 2017

• GSK US Pharmaceuticals, Philadelphia, PA, USA 

o 2016, Head of Meningococcal franchise, GSK Vaccines Business Unit 

o 2015-2017, Head Health Systems (Integrated Delivery Network & Kaiser Customers)

• Novartis Vaccines Cambridge, MA, USA

o 2014-2015, Head Meningococcal franchise, US 

o 2014, Global commercial integration lead for sale of business unit from Novartis to 

GSK Vaccines

o 2013-2014, Front line sales leadership rotation

• Novartis Vaccines and Diagnostics, 2011-2013 - Global Head of Strategy

• McKinsey & Company Florham Park, NJ, USA and Mumbai, India, 2003-2010

o Associate Principal- Responsible for leading client engagements, new business 

development, new knowledge, and teams Core Industries: Pharmaceutical and 

Medical Device, Infrastructure, Real Estate and Energy

• ZS Associates Evanston, IL, USA, Summer 2002 - Consultant, Healthcare practice –

Medical device company channel strategy

• IGEN INTERNATIONAL INC. (Biotech acquired by Roche in June 2003) Gaithersburg, MD, 

USA, 1999-2000 - Engineer, R&D and Product Development

EDUCATION

• KELLOGG SCHOOL OF MANAGEMENT Evanston, IL, USA 

NORTHWESTERN UNIVERSITY

o Master of Business Administration degree, June 2003

o Masters of Management & Manufacturing (MMM): Focus on Strategy, Operations 

and Biotechnology

• NORTHWESTERN UNIVERSITY Evanston, IL, USA

o Master of Science degree in mechanical engineering 

• UNIVERSITY OF MUMBAI Mumbai, India

o Bachelor of Engineering degree in Mechanical Engineering - First Class with 

Honors

OTHER INFORMATION

• Indian National Sailing Champion in 1991. Represented India at the international level in Argentina, Sweden and China

• Cadet Leader, at Sea Cadet Corps, a voluntary organization, trained ~800 teenage cadets over 6 years

PROF. LULU C. BRAVO, MD

Professor Emeritus College of Medicine, 

University of the Philippines Manila

Lulu Bravo is a Professor Emeritus at the College of Medicine, University of the Philippines Manila. She is the former Vice Chancellor for Research and Executive Director of the National Institutes of Health, University of the Philippines Manila.

At present, she is President of the Immunization Partners in Asia Pacific (IPAP) and current Executive Director and past President of the International Society of Tropical Pediatrics (ISTP) 2009-2011, past Chair of the Asian Strategic Alliance for Pneumococcal Disease Prevention (ASAP), and former president of the Asian Society for Pediatric Infectious Disease (ASPID).She 

has served in various capacities in many other Asian medical and professional societies as well as in Philippine health associations including the Philippine Foundation for Vaccination (PFV) of which she is the founding President. She is also a member of the Rota Council, Pneumococcal Awareness Council of Experts (PACE) and member of the TWG of the Dengue Vaccine Initiative (DVI). Her work has earned for her various honors and awards in the academic and research fields, including the Dr. Jose P. Rizal Memorial Award for Academe, the 2012 Asian Outstanding 

Pediatrician Award given by the Asia Pacific Pediatric Association and 2018 Outstanding 

Professional in Medicine given by the PRC of the Philippines.

Dr. Lulu Bravo completed her MD, pediatric residency and subspecialty training in infectious disease at Philippine General Hospital-College of Medicine of the University of the Philippines Manila. She supplemented her fellowship in pediatric infectious disease at the University of Texas Southwestern Health Science Center in Dallas, USA in 1986.

About GSK

GSK – one of the world’s leading research-based pharmaceutical and health care companies – is committed to improving the quality of human life by enabling people to do more, feel better and live

longer. For further information please visit www.gsk.com/about-us/ .

About PFV

The Philippine Foundation for Vaccination Inc. is a non-stock, non-profit organization to protect and advocate for the promotion of vaccination as essential to disease prevention, especially among infants 

and children. For further information please visit http://www.philvaccine.org/